QuidelOrtho
QDEL
$40.82
Share price
1.04%
Change (1 day)
-55.92%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Net assets
Net assets on the balance sheet as of December 2023 : $5.00 B
According to QuidelOrtho's latest financial reports the company has $5.00 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
QuidelOrtho - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $5.00 B | 1.44% |
| 2022-12-31 | $4.93 B | 155.76% |
| 2021-12-31 | $1.92 B | 44.77% |
| 2020-12-31 | $1.33 B | 138.06% |
| 2019-12-31 | $0.55 B | 31.54% |
| 2018-12-31 | $0.42 B | 87.4% |
| 2017-12-31 | $0.22 B | 13.2% |
| 2016-12-31 | $0.20 B | -8.25% |
| 2015-12-31 | $0.21 B | -10.75% |
| 2014-12-31 | $0.24 B | 9.49% |
| 2013-12-31 | $0.22 B | 12.01% |
| 2012-12-31 | $0.19 B | 7.76% |
| 2011-12-31 | $0.18 B | 64.76% |
| 2010-12-31 | $0.11 B | -11.02% |
| 2009-12-31 | $0.12 B | 6.05% |
| 2008-12-31 | $0.11 B | 10.71% |
| 2007-12-31 | $0.10 B | 4.29% |
| 2006-12-31 | $0.10 B | 18.38% |
| 2005-12-31 | $87.24 M | -3.26% |
| 2004-12-31 | $90.18 M | 0.45% |
| 2003-12-31 | $89.78 M | 43.06% |
| 2002-12-31 | $62.75 M | 3.89% |
| 2001-12-31 | $60.4 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $46.84 B | 835.74% | 🇺🇸 USA |
 Becton Dickinson BDX | $25.33 B | 406.06% | 🇺🇸 USA |
 Danaher DHR | $53.49 B | 968.54% | 🇺🇸 USA |
 PerkinElmer
PKI | $8.03 B | 60.49% | 🇺🇸 USA |
 OraSure Technologies OSUR | $0.43 B | -91.40% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $0.36 B | -92.65% | 🇺🇸 USA |